Class II · Moderate risk Terminated
Desloratadine Tablets USP 5mg a) 100 count
Reason CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
Up&Up loratadine orally disintegrating tablets
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Superpotent Drug: Out Of Specification (OOS) result for Assay.
What was recalled
Up&Up loratadine orally disintegrating tablets, USP, 10 mg, 30-count tablets per box, Distributed by Target Corp, Minneapolis, MN 55403; NDC 11673-527-31, UPC 3 5166052731 5
- Recalling firm
- Ohm Laboratories, Inc.
- NDC code
- 11673-527-31
- Origin
- NJ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0036-2016
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Loratadine recalls
See all
Class II · Moderate risk Ongoing
Claritin Allergy Liq Chldrns Grape 2 Floz Sku 900834 Claritin…
Reason CGMP Deviations: product held outside appropriate storage temperature conditions.
Class III · Low risk Terminated
AllerClear D-24 hr
Reason Failed Moisture Limits
Class III · Low risk Terminated
Loratadine-D Extended-Release Tablets
Reason Failed Moisture Limits
Class II · Moderate risk Terminated
Children's Loratadine Oral Solution USP
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.